Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY


  • Kendra Vehik
  • Steven W. Fiske
  • Chad A. Logan
  • Daniel Agardh
  • Corrado Cilio
  • William Hagopian
  • Olli Simell
  • Merja Roivainen
  • Jin-Xiong She
  • Thomas Briese
  • Sami Oikarinen
  • Heikki Hyoty
  • Anette-G. Ziegler
  • Marian Rewers
  • Åke Lernmark
  • Beena Akolkar
  • Jeffrey P. Krischer
  • Brant R. Burkhardt

Summary, in English

BackgroundThe vast array and quantity of longitudinal samples collected in The Environmental Determinants of Diabetes in the Young study present a series of challenges in terms of quality control procedures and data validity. To address this, pilot studies have been conducted to standardize and enhance both biospecimen collection and sample obtainment in terms of autoantibody collection, stool sample preservation, RNA, biomarker stability, metabolic biomarkers and T-cell viability. Research Design and MethodsThe Environmental Determinants of Diabetes in the Young is a multicentre, international prospective study (n=8677) designed to identify environmental triggers of type 1 diabetes (T1D) in genetically at-risk children from ages 3months until 15years. The study is conducted through six primary clinical centres located in four countries. ResultsAs of May 2012, over three million biological samples and 250 million total data points have been collected, which will be analysed to assess autoimmunity status, presence of inflammatory biomarkers, genetic factors, exposure to infectious agents, dietary biomarkers and other potentially important environmental exposures in relation to autoimmunity and progression to T1D. ConclusionsDetailed procedures were utilized to standardize both data harmonization and management when handling a large quantity of longitudinal samples obtained from multiple locations. In addition, a description of the available specimens is provided that serve as an invaluable repository for the elucidation of determinants in T1D focusing on autoantibody concordance and harmonization, transglutaminase autoantibody, inflammatory biomarkers (T-cells), genetic proficiency testing, RNA lab internal quality control testing, infectious agents (monitoring cross-contamination, virus preservation and nasal swab collection validity) and HbA(1c) testing. Copyright (c) 2013 John Wiley & Sons, Ltd.


  • Diabetes and Celiac Unit
  • Diabetes - Immunovirology
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year







Diabetes/Metabolism Research & Reviews





Document type

Journal article


John Wiley and Sons


  • Endocrinology and Diabetes


  • quality control
  • data integrity
  • stool sample preservation
  • RNA
  • biomarker stability
  • metabolic biomarkers
  • T-cell viability



Research group

  • Diabetes and Celiac Unit
  • Diabetes - Immunovirology


  • ISSN: 1520-7552